IP Library › Granted Patent US 8,592,568
Granted Patent B2
US 8,592,568 · App. 13/085,799 · Granted Nov 26, 2013

Nucleic acid probes and methods for detecting plasmodium parasites

Inventors: Jyotsna S. Shah (Santa Clara, CA); Danuta Wronska (Raleigh, NC); Helena Weltman (Los Altos, CA); Nick S. Harris (Monterey, CA); Suzanne Scherini-Ward (Santa Clara, CA); Oliva Mark (San Jose, CA)
Assignee: ID-Fish Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,592,568
App. No.
13/085,799
Granted
Nov 26, 2013
Kind
B2
Abstract

This invention relates to novel nucleic acid probes and methods for detecting Plasmodium parasites as well as detecting different Plasmodium parasites selectively from one another.

Claims (6)

1. A composition suitable for detecting Plasmodium in a sample, said composition comprising one or more of: a probe consisting of PV1 [SEQ ID NO.: 7] or the full-length complementary sequence thereof, and a label; a probe consisting of PV2 [SEQ ID NO.: 8] or the full-length complementary sequence thereof, and a label; and a probe consisting of PF2 [SEQ ID NO.: 10] or the full-length complementary sequence thereof, and a label.

2. The composition of claim 1 , wherein said composition comprises the probe consisting of PV1 [SEQ ID NO.: 7] or the full-length complementary sequence thereof, and a label.

3. The composition of claim 1 , wherein said composition comprises the probe consisting of PV2 [SEQ ID NO.: 8] or the full-length complementary sequence thereof, and a label.

4. The composition of claim 1 wherein said composition comprises the probe consisting of PF2 [SEQ ID NO.:10] or the full-length complementary sequence thereof, and a label.

5. The composition of claim 1 , wherein the Plasmodium to be detected is Plasmodium vivax and said composition comprises one or more probes selected from the group consisting of: a probe consisting of PV1 [SEQ ID NO.: 7] or the full-length complementary sequence thereof, and a label; and a probe consisting of PV2 [SEQ ID NO.: 8] or the full-length complementary sequence thereof, and a label.

6. The composition of claim 1 , wherein the Plasmodium to be detected is Plasmodium falciparum and said composition comprises the probe consisting of PF2 [SEQ ID NO.:10] or the full-length complementary sequence thereof, and a label.

Continuity (2)
Continuation 11998251 · Nov 29, 2007
Related Publication 20110287422A1 · Nov 24, 2011